| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |